The Dengue Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Dengue Treatment Global Market Report shows that the market has significantly expanded in recent years. The value has been projected to increase from $2.10 billion in 2024 to $2.35 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 12.0%.
The Dengue Treatment Global Market is anticipated to expand to a size of $3.64 billion by the year 2029, with a Compound Annual Growth Rate (CAGR) of 11.6%.
Download Your Free Sample of the 2025 Dengue Treatment Market Report and Uncover Key Trends Now!The key drivers in the dengue treatment market are:
•Development of universally applicable dengue vaccines
•Expansion of dengue vaccine availability
•Advancement of public-private partnerships
•Growth of telemedicine in the sector and improvements in policy frameworks
The dengue treatment market covered in this report is segmented –
1) By Type: Vaccines, Acetaminophen
2) By Route Of Administration: Parenteral, Oral
3) By Drug Class: Nsaids, Antibiotics, Corticosteroids
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospital, Specialty Clinics, Home Healthcare
Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines
2) By Acetaminophen: Oral Acetaminophen, Intravenous Acetaminophen
The key trends in the dengue treatment market are:
•The development of next-generation dengue vaccines is one of the notable trends.
•AI-based drug discovery is emerging as a significant trend in this market.
•The use of smart contact tracing tools is increasingly shaping the future.
•Efforts are underway for the production of 3D-printed vaccines and the application of CRISPR for virus targeting.
Major players in the dengue treatment market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Merck & Co Inc.
• Sanofi S.A.
• Abbott Laboratories
• Novartis International AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim GmbH
• Hetero Labs Limited
• Sun Pharmaceutical Industries Limited
• Dr. Reddy’s Laboratories Limited
• Cipla Incorporated
• Emergent BioSolutions Inc.
• Bharat Biotech International Limited
• Inovio Pharmaceuticals Inc.
• Gennova Biopharmaceuticals Ltd.
• ABIVAX S.A.
• Cadila Healthcare Limited
• Biological E. Limited
Asia-Pacific was the largest region in the dengue treatment in 2024